The risk of developing metastatic disease in colorectal cancer is related to CD105-positive vessel count
Authors:
- 13 April 2006
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 93 (6) , 446-455
Abstract
Background and Objectives Angiogenesis is a complex multistep process that involves extracellular matrix remodeling, migration and proliferation of endothelial cells, and morphogenesis of microvessels. CD105 (endoglin), a co-receptor of the TGF-β superfamily, was proposed as a marker of neovascularization in solid malignancies. The aim of this study was to evaluate retrospectively the effect of CD105-assessed angiogenesis on the risk of developing metastatic disease in colorectal cancer (CRC). Methods One hundred and twenty-five paraffin-embedded samples were analyzed by immunohistochemical methods using a CD105 monoclonal antibody. The median follow-up was 70.8 months. Survivals were calculated from actuarial estimates, and logistic regression predicted the risk of developing metastatic disease. Results The CD105-vessel count was strongly correlated with the occurrence of metastatic disease. The median CD105-positive vessels in patients with and without metastatic disease were 24.7 and 13.2 vessels/mm2, respectively (P < 0.001). For each one microvessel increase in the vessels count per 400× field, there was a 1.42-fold increase in the risk of metastatic disease (P < 0.001). Conclusions The assessment of tumor angiogenesis with anti-CD105 was not sufficient for its use as a surrogate end point for survival because of the amount of survival variability explained was only 8% in absence of metastatic disease. In contrast, multivariate logistic regression analysis revealed that CD105-vessels count can identify patients at high risk of metastatic disease. J. Surg. Oncol. 2006;93:446–455.Keywords
This publication has 40 references indexed in Scilit:
- Endoglin Expression Is Regulated by Transcriptional Cooperation between the Hypoxia and Transforming Growth Factor-β PathwaysJournal of Biological Chemistry, 2002
- Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumoursEuropean Journal of Cancer, 2002
- Strategies for vascular targeting in tumorsInternational Journal of Cancer, 2002
- Prognostic significance of angiogenesis in clinically localized prostate cancer (staining for Factor VIII-related antigen and CD34 Antigen)Prostate Cancer and Prostatic Diseases, 1997
- Prognostic value of angiogenesis in gastro-intestinal tumoursEuropean Journal of Cancer, 1996
- Identification and expression of two forms of the human transforming growth factor‐β‐binding protein endoglin with distinct cytoplasmic regionsEuropean Journal of Immunology, 1993
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI: Journal of the National Cancer Institute, 1990
- Measures of dependence for censored survival dataBiometrika, 1988
- A new look at the statistical model identificationIEEE Transactions on Automatic Control, 1974